Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory markers and suicidal attempts in depressed patients: A review.
Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, Olivieri L, Di Renzo F, Di Marco A, Fornaro M, Orsolini L, Valchera A, Iasevoli F, Mazza M, Perna G, Martinotti G, Di Giannantonio M. Marini S, et al. Among authors: matarazzo i. Int J Immunopathol Pharmacol. 2016 Dec;29(4):583-594. doi: 10.1177/0394632015623793. Epub 2016 Jan 4. Int J Immunopathol Pharmacol. 2016. PMID: 26729403 Free PMC article. Review.
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders.
De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, Perna G, Conti C, Segura-García C, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: matarazzo i. Curr Pharm Des. 2016;22(33):5144-5162. doi: 10.2174/1381612822666160701084447. Curr Pharm Des. 2016. PMID: 27396597 Review.
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: matarazzo i. CNS Spectr. 2017 Aug;22(4):342-347. doi: 10.1017/S1092852916000572. Epub 2016 Oct 5. CNS Spectr. 2017. PMID: 27702411
Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo ALC, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, Di Bartolomeis A, De Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: matarazzo i. CNS Neurol Disord Drug Targets. 2017;16(1):65-92. doi: 10.2174/1871527315666161025140111. CNS Neurol Disord Drug Targets. 2017. PMID: 27781949 Review.
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review.
Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D. Orsolini L, et al. Among authors: matarazzo i. Curr Neuropharmacol. 2018;16(5):583-606. doi: 10.2174/1570159X16666180119144538. Curr Neuropharmacol. 2018. PMID: 29357805 Free PMC article. Review.
An update of safety of clinically used atypical antipsychotics.
Orsolini L, Tomasetti C, Valchera A, Vecchiotti R, Matarazzo I, Vellante F, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Mazza M, Perna G, Carano A, De Bartolomeis A, Di Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: matarazzo i. Expert Opin Drug Saf. 2016 Oct;15(10):1329-47. doi: 10.1080/14740338.2016.1201475. Epub 2016 Jul 4. Expert Opin Drug Saf. 2016. PMID: 27347638 Review.
The endocannabinoid system: a putative role in neurodegenerative diseases.
Di Iorio G, Lupi M, Sarchione F, Matarazzo I, Santacroce R, Petruccelli F, Martinotti G, Di Giannantonio M. Di Iorio G, et al. Among authors: matarazzo i. Int J High Risk Behav Addict. 2013 Dec;2(3):100-6. doi: 10.5812/ijhrba.9222. Epub 2013 Dec 14. Int J High Risk Behav Addict. 2013. PMID: 24971285 Free PMC article. Review.
Treatment-resistant insomnia treated with pregabalin.
Di Iorio G, Matarazzo I, Di Tizio L, Martinotti G. Di Iorio G, et al. Among authors: matarazzo i. Eur Rev Med Pharmacol Sci. 2013 Jun;17(11):1552-4. Eur Rev Med Pharmacol Sci. 2013. PMID: 23771546 Free article.
19 results